Navellier & Associates Inc Omnicell, Inc Transaction History

Navellier & Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$105.64 - $129.11 $4.75 Million - $5.81 Million	-45,000 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$120.68 - $180.51 $392,572 - $587,199	-3,253 Reduced 6.74%	45,000 $5.83 Million
Q4 2021 Feb 14, 2022	SELL	$153.26 - $183.62 $284,144 - $340,431	-1,854 Reduced 3.7%	48,253 $8.71 Million
Q3 2021 Oct 28, 2021	BUY	$141.84 - $160.88 $7.11 Million - $8.06 Million	50,107 New	50,107 $7.44 Million

274

44.3M

224K

35.7K

Ticker OMCL
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 44,288,800
Market Cap $1.87B
Description
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Navellier & Associates Inc with notifications on news.